BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11916513)

  • 21. Acute erythroleukemia: diagnosis and management.
    Santos FP; Bueso-Ramos CE; Ravandi F
    Expert Rev Hematol; 2010 Dec; 3(6):705-18. PubMed ID: 21091147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
    Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
    Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
    Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
    J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5q-anomaly in a patient with erythroleukemia (M6-FAB classification).
    Donti E; Mecucci C; Rosetti A; Tabilio A; Venti G
    Haematologica; 1985; 70(5):424-7. PubMed ID: 3937779
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis.
    Mazzella FM; Kowal-Vern A; Shrit MA; Wibowo AL; Rector JT; Cotelingam JD; Collier J; Mikhael A; Cualing H; Schumacher HR
    Am J Clin Pathol; 1998 Nov; 110(5):590-8. PubMed ID: 9802343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.
    Chen Y; Pourabdollah M; Atenafu EG; Tierens A; Schimmer A; Chang H
    Leuk Res; 2017 Oct; 61():39-43. PubMed ID: 28886412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome.
    Park DC; Ozkaya N; Lovitch SB
    Histopathology; 2017 Aug; 71(2):316-321. PubMed ID: 28261852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting erythroleukemia.
    Arber DA
    Curr Opin Hematol; 2017 Mar; 24(2):146-151. PubMed ID: 27875373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic study of 75 erythroleukemias.
    Lessard M; Struski S; Leymarie V; Flandrin G; Lafage-Pochitaloff M; Mozziconacci MJ; Talmant P; Bastard C; Charrin C; Baranger L; Hélias C; Cornillet-Lefebvre P; Mugneret F; Cabrol C; Pagès MP; Fert-Ferret D; Nguyen-Khac F; Quilichini B; Barin C; Berger R;
    Cancer Genet Cytogenet; 2005 Dec; 163(2):113-22. PubMed ID: 16337853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic heterogeneity of erythroblasts in erythroblastic leukemia revealed by monoclonal antibodies.
    Gupta AD; Dhond SR
    Am J Hematol; 1988 Sep; 29(1):12-7. PubMed ID: 3052043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute erythroblastic leukemia. Cytological, cytogenetic and phenotypic studies in one case.
    Soler J; Pujol-Moix N; Bosch MA; Guanyabens C; Aventin A; Boque C; Brunet S
    Acta Haematol; 1989; 82(2):102-5. PubMed ID: 2508392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification.
    Cervera N; Carbuccia N; Mozziconacci MJ; Adélaïde J; Garnier S; Guille A; Murati A; Chaffanet M; Vey N; Birnbaum D; Gelsi-Boyer V
    Blood Cancer J; 2017 Aug; 7(8):e594. PubMed ID: 28841205
    [No Abstract]   [Full Text] [Related]  

  • 33. [Erythroleukemias. Recategorization according to the World Health Organization's criteria].
    Peruzzo LB; Bertone MC; Mathey MD; Rossi JG; Baialardo EM; Felice MS
    Medicina (B Aires); 2019; 79(1):1-5. PubMed ID: 30694182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
    Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
    Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.
    Germing U; Strupp C; Kuendgen A; Aivado M; Giagounidis A; Hildebrandt B; Aul C; Haas R; Gattermann N
    Br J Haematol; 2006 Jan; 132(2):162-7. PubMed ID: 16398650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major karyotypic abnormalities in a near-tetraploid erythroleukemia.
    Kocova MJ; Sandberg AA
    Cancer Genet Cytogenet; 1985 Jun; 17(2):143-50. PubMed ID: 3857966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pure erythroleukemia: a case report and literature review.
    Latif N; Salazar E; Khan R; Villas B; Rana F
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):283-90. PubMed ID: 20505651
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute erythroleukemia--M6B.
    Mohanty R; Dash B; Chawla SC; Paul HS
    Indian J Pathol Microbiol; 2001 Oct; 44(4):461-2. PubMed ID: 12035366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomes and causation of human cancer and leukemia. LIII. Comprehensive cytogenetic analysis of an erythroleukemia.
    Gibas Z; Becher R; Sandberg AA
    Cancer Genet Cytogenet; 1983 Nov; 10(3):241-53. PubMed ID: 6578871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of de novo early erythroblastic leukemia supporting a proposal of AML M6 'variant'.
    Yonezumi M; Miyagishima T; Kudo M; Choi GH; Kishimoto A; Miura Y; Nakagawa M; Okabe M
    Leuk Lymphoma; 2000 Nov; 39(5-6):667-8. PubMed ID: 11392312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.